SCHEMBL3475253

SCHEMBL3475253

CCn1c(=O)c(Cc2ccccc2)nc2ccc(-c3cccc(OC(F)(F)F)c3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC5 Q9UL62 3/20 0.45
MAOA P21397 3/20 0.43
SERPINE1 P05121 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GRIN1 Q05586 3/20 0.41
GRIN2B Q13224 3/20 0.41
MMP9 P14780 2/20 0.41
MAOB P27338 2/20 0.41
MLNR O43193 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ADRA1A P35348 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3435814 0.89 TRPC5 (0.47) TRPC5MAOASERPINE1GRIN1GRIN2B
SCHEMBL3474853 0.83 PDE4A (0.43) SERPINE1KDM4EALDH1A1LMNAHPGD
SCHEMBL3431393 0.81 SERPINE1 (0.43) TRPC5SERPINE1MLNRADORA3ADRA2B
SCHEMBL3380300 0.80 KDM4E (0.46) MAOASERPINE1KDM4EALDH1A1HPGD
SCHEMBL3434956 0.75 ALDH1A1 (0.54) TRPC5KDM4EALDH1A1LMNAHPGD
SCHEMBL3347869 0.74 FFAR1 (0.47) TRPC5SERPINE1GRIN1GRIN2BPPARG
SCHEMBL3473822 0.74 FFAR1 (0.43) SERPINE1FFAR1FFAR4
SCHEMBL3414007 0.73 KDM5A (0.41) TRPC5GRIN1GRIN2BPDE10A
SCHEMBL982499 0.73 MAPK1 (0.75) MAOAKDM4EALDH1A1LMNAHPGD
SCHEMBL3474781 0.73 PDE10A (0.44) TRPC5KDM4EALDH1A1HPGDGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113461-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS GILEAD PALO ALTO, INC. (US) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113461-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS KCNH1, KCNJ2, KCNH2 TRPC5 44/4885MAOA 1881/4885SERPINE1 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.